Evolution of the Average Target: Albemarle Corporation

Evolution of the Target Price: Albemarle Corporation

Changes in Analyst Recommendations: Albemarle Corporation

879c54c5b82888f5c8cfb.NO9OT1dL61xq3KsnrLglqGvpN85u5eNsrRzrCL8zKZ8.eoMDJiUJ3T8jjMEW_-Ed-A_EYKZakbk0wTGlQPppePpBhScNI3LTaiSZ7g~bcdce75a5faf869c3a4faeae51984535
06-03 Analyst recommendations: Chipotle, Fedex, Yum! Brands, Dollar General, Humana… Zonebourse
06-02 Berenberg Raises Price Target on Albemarle to $192 From $153, Keeps Hold Rating MT
05-26 Albemarle Likely to Continue Growing Volumes Over the Coming Years, RBC Says MT
05-26 RBC Lifts Price Target on Albemarle to $257 From $253, Keeps Outperform Rating MT
05-13 Scotiabank Adjusts Price Target on Albemarle to $215 From $200, Maintains Sector Outperform Rating MT
05-12 Deutsche Bank Adjusts Albemarle Price Target to $250 From $210, Maintains Buy Rating MT
05-11 Albemarle's EBITDA to Benefit From Higher Lithium Prices, RBC Says MT
05-11 Jefferies Adjusts Price Target on Albemarle to $244 From $230 MT
05-11 Argus Adjusts Price Target on Albemarle to $230 From $185 MT
05-11 RBC Capital Adjusts Albemarle Price Target to $253 From $245, Maintains Outperform Rating MT
05-08 UBS Raises Price Target on Albemarle to $264 From $230, Maintains Buy Rating MT
05-07 Baird Adjusts Albemarle Price Target to $236 From $210 MT
04-28 Morgan Stanley Adjusts Price Target on Albemarle to $189 From $170, Maintains Equalweight Rating MT
04-27 HSBC Adjusts Price Target on Albemarle to $220 From $200, Maintains Buy Rating MT
04-24 RBC Adjusts Price Target on Albemarle to $245 From $216, Maintains Outperform Rating MT
04-22 Analyst recommendations: Albemarle, Biogen, Qualcomm, Twilio, Lyondellbasell… Zonebourse
04-22 Rothschild & Co Redburn Downgrades Albemarle to Neutral From Buy, Adjusts PT to $188 From $185 MT
04-21 Citigroup Adjusts Price Target on Albemarle to $210 From $190, Maintains Neutral Rating MT
04-17 Albemarle Shares Fall After Baird Downgrade MT
04-17 Baird Downgrades Albemarle to Neutral From Outperform, Price Target is $210 MT
04-17 Analyst recommendations: Albemarle, Newmont Corp, Texas Instruments, The Clorox Company, Oxy… Zonebourse
04-13 Oppenheimer Adjusts Price Target on Albemarle to $222 From $216, Maintains Outperform Rating MT
04-09 UBS Adjusts Price Target on Albemarle to $230 From $220, Maintains Buy Rating MT
02-23 Argus Lifts Albemarle Price Target to $185 From $140 MT
02-23 Berenberg Raises Price Target on Albemarle to $153 From $135, Keeps Hold Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+29.14%
+15.8%
+7.54%
+12.6%
+19.43%
-0.6%
-5.56%
+8.39%
+11.85%
+11.6%
Average +11.02%
Weighted average by Cap. +11.84%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
166.56USD
Average target price
214.51USD
Spread / Average Target
+28.79%
High Price Target
264.00USD
Spread / Highest target
+58.50%
Low Price Target
83.28USD
Spread / Lowest Target
-50.00%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Berenberg Bank
RBC Capital Markets
Scotiabank
Deutsche Bank Securities
Jefferies & Co.
Argus
UBS
Baird
Morgan Stanley
HSBC
Rothschild & Co Redburn
Citigroup
Oppenheimer
Evercore ISI
BofA Securities
JPMorgan Chase
Mizuho Securities
Wells Fargo Securities
BMO Capital
Vertical Research
DBS Bank
TD Cowen
KeyBanc Capital Markets
Truist Securities
Piper Sandler
Credit Suisse
Cowen
Goldman Sachs
Loop Capital
J.P. Morgan Chase
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
166.56USD
Average target price
214.51USD
Spread / Average Target
+28.79%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALB Stock
  4. Consensus Albemarle Corporation
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!